Bank of New York Mellon’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bank of New York Mellon’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14	Closed	-$9.72K	–	4404
2023 Q3	$9.72K	Hold	14	–	–	﹤0.01%	4299
2023 Q2	$63.2K	Hold	14	–	–	﹤0.01%	4138
2023 Q1	$36.5K	Hold	14	–	–	﹤0.01%	4245
2022 Q4	$35.9K	Hold	14	–	–	﹤0.01%	4285
2022 Q3	$54K	Hold	14	–	–	﹤0.01%	4309
2022 Q2	$37K	Sell	14 -62	-82%	-$161K	﹤0.01%	4411
2022 Q1	$244K	Hold	76	–	–	﹤0.01%	4136
2021 Q4	$475K	Buy	76 +12	+19%	+$92.1K	﹤0.01%	3840
2021 Q3	$588K	Buy	64 +19	+42%	+$163K	﹤0.01%	3718
2021 Q2	$454K	Buy	45 +38	+543%	+$624K	﹤0.01%	3812
2021 Q1	$128K	Sell	7 -5	-42%	-$58.4K	﹤0.01%	4134
2020 Q4	$73K	Buy	+12	New	+$47.1K	﹤0.01%	4115
2018 Q1	–	Hold	0	–	-$21K	–	4425
2017 Q4	–	Hold	0	–	–	–	4301
2016 Q4	–	Hold	0	–	-$21K	–	4319
2016 Q3	–	Hold	0	–	–	–	4216
2016 Q2	–	Hold	0	–	–	–	4246
2016 Q1	–	Hold	0	–	–	–	4102
2015 Q4	–	Hold	0	–	–	–	4126
2015 Q3	–	Hold	0	–	–	–	4096
2015 Q2	–	Hold	0	–	–	–	4004
2015 Q1	–	Hold	0	–	–	–	4008
2014 Q4	–	Hold	0	–	–	–	4145
2014 Q3	–	Hold	0	–	–	–	4111
2014 Q2	–	Hold	0	–	–	–	3971
2014 Q1	–	Hold	0	–	–	–	3978
2013 Q4	–	Hold	0	–	–	–	3959
2013 Q3	–	Hold	0	–	–	–	3937
2013 Q2	–	Hold	0	–	–	–	3848

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon's SEEL Position: Q4 2023 in Review

Bank of New York Mellon sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 14 shares — an estimated $9.72K sold.

Bank of New York Mellon first reported a position in SEEL in Q4 2020 and held it in 12 quarters. The position peaked at $588K in Q3 2021. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

Bank of New York Mellon reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Bank of New York Mellon sold 14 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $9.72K.
Bank of New York Mellon first reported a position in Seelos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
Bank of New York Mellon's Seelos Therapeutics, Inc. Common Stock position peaked at $588K in Q3 2021.
32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.